Creative Biolabs-Immuno-oncology

Anti-CEACAM5 (clone ChIO1G) SynExpress E1-Cy2-I17-P Modified CD8+ T cells (CAT#: ITS-1224-CR805)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CEACAM5 (clone ChIO1G). We employs the Retrovirus (EF1α-Cy2-IL-17-PstI) vector components and the SynExpress system of the Exons Inversion/Delayed feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CEACAM5
Clone
ChIO1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
EF1α
Effector Gene
IL-17
Insertion Sites
PstI
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.9
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving